🛡 Immunotherapy - JMPS · Scour

targeted therapy or immunotherapy 🎯Delivery Systems

notes.pinboard.in·4d

New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer 🎯Delivery Systems

medicalxpress.com·1d

A Combination Treatment is Claimed to Produce Sizable Life Extension in Aged Mice ⏳Longevity Biotech

fightaging.org·19h

Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy 🔬Nucleic Acid Drugs

Targeting PD-1+ T cells with chimeric antigen receptors to reduce the HIV reservoir 🔬Nucleic Acid Drugs

hybridcars.einnews.com·6d

Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years ⏳Longevity Biotech

scitechdaily.com·1d

mbiomics raises €30M Series A to take its microbiome cancer co-therapy into clinical trials 🦠Microbiome IP

thenextweb.com·1d

A Milestone-Based Framework for Characterizing Time-Varying Treatment Effects in Immunotherapy Trials ⏰Patent Cliffs

A self-reinforcing copper nanoplatform for synergistic anti-tumor immunotherapy through cuproptosis, calcium overload, and PD-L1 inhibition 🔬DNA Nanotechnology

sciencedirect.com·1d

Single cell Raman spectroscopic profiles predict treatment responses in patients with de novo acute myeloid leukemia 🔬Nucleic Acid Drugs

frontiersin.org·2d

Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing 🧬Food Technology

genengnews.com·3d

Science in Space ☕Caffeine Science

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle ... ⏳Longevity Biotech

Sam Neill announces he is cancer-free after taking part in Australian clinical trial: ‘I’m very, very excited’ 🧫Cell Therapy

theguardian.com·2d

Legend Biotech: Undervalued Leader In The CAR-T Race (NASDAQ:LEGN) 🌐Regulatory Arbitrage

seekingalpha.com

·6d

Genetic discovery may explain why pancreatic cancer is so difficult to treat 🧫Cell Therapy

medicalxpress.com·12h

TWICEBEE: A Two-stage Intra-patient Curve-free Bayesian Decision-Theoretic Dose Escalation Design ☣️Bioweapons

Arcus Biosciences: TIGIT In The Rearview Mirror, But Market Pricing A Bit Too Aggressively For Now 🌐Regulatory Arbitrage

seekingalpha.com

·3d

Protonated porphyrin-based J-aggregates for photothermal/NO combination therapy against bacterial infections 💊Gastric Delivery

sciencedirect.com·1d

How killer T cells attack tumors in 3D could sharpen future cancer immunotherapy 🧫Cell Therapy

medicalxpress.com·1d

Log in to enable infinite scrolling